OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
Alberto San Francisco Ramos, Carolina Liu-Sanchez, Tatiana Bovill Rose, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 266-282
Open Access | Times Cited: 6
Alberto San Francisco Ramos, Carolina Liu-Sanchez, Tatiana Bovill Rose, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 266-282
Open Access | Times Cited: 6
Showing 6 citing articles:
Safety comparison between Pfizer BNT162b2, Moderna mRNA-1273, and AstraZeneca AZD1222 in a Nationwide prospective cohort survey at the beginning of the severe acute respiratory syndrome coronavirus 2 vaccination in Japan
Suminobu Ito, Nao Tsuchida, Susumu Kusunoki, et al.
Vaccine (2025) Vol. 49, pp. 126754-126754
Open Access
Suminobu Ito, Nao Tsuchida, Susumu Kusunoki, et al.
Vaccine (2025) Vol. 49, pp. 126754-126754
Open Access
The COVID‐19 vaccine ChAdOx1 is opsonized by anti‐vector antibodies that activate complement and promote viral vector phagocytosis
Eija Nissilä, Leo Starck, E. Aho, et al.
Scandinavian Journal of Immunology (2025) Vol. 101, Iss. 2
Open Access
Eija Nissilä, Leo Starck, E. Aho, et al.
Scandinavian Journal of Immunology (2025) Vol. 101, Iss. 2
Open Access
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model
Clive Pritchard, Lucie Kutikova, Richard Pitman, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 187-187
Open Access
Clive Pritchard, Lucie Kutikova, Richard Pitman, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 187-187
Open Access
Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice
Tongyao Mao, Xiaozhong Peng, Shibo Jiang, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Tongyao Mao, Xiaozhong Peng, Shibo Jiang, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 802-802
Open Access | Times Cited: 2
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 802-802
Open Access | Times Cited: 2
Reactogenicity Differences between COVID-19 Vaccines: A Prospective Observational Study in the United States and Canada
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
